Drug interactions
clopidogrel + omega-3 fatty acids
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Overview
Potential additive antiplatelet effect may increase bleeding risk; prescription omega‑3 labels warn of bleeding with antiplatelets/anticoagulants.
Mechanism of action
Pharmacodynamic: EPA/DHA reduce platelet aggregation (e.g., decreased thromboxane A2) alongside clopidogrel’s P2Y12 inhibition.
Clinical management
Use the combination with caution; monitor for bleeding (bruising, epistaxis, GI bleed). Avoid high omega‑3 doses; consider holding before high‑bleed‑risk procedures per local protocol.
Drug reference
References
- Lovaza (omega-3-acid ethyl esters) Prescribing Information — FDA Label
- Vascepa (icosapent ethyl) Prescribing Information — FDA Label
- Omega-3 Fatty Acids (monograph): Drug information — Lexicomp
Frequently asked questions
Can I take clopidogrel with omega-3 fatty acids?
The interaction is rated: Moderate. Potential additive antiplatelet effect may increase bleeding risk; prescription omega‑3 labels warn of bleeding with antiplatelets/anticoagulants.
How serious is the interaction between clopidogrel and omega-3 fatty acids?
The interaction is rated: Moderate. Evidence level: Moderate.
How is the interaction between clopidogrel and omega-3 fatty acids managed?
Use the combination with caution; monitor for bleeding (bruising, epistaxis, GI bleed). Avoid high omega‑3 doses; consider holding before high‑bleed‑risk procedures per local protocol.
Why do clopidogrel and omega-3 fatty acids interact?
Pharmacodynamic: EPA/DHA reduce platelet aggregation (e.g., decreased thromboxane A2) alongside clopidogrel’s P2Y12 inhibition.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.